UB begins groundbreaking study on 'net effect' on patients of HIV treatments, other drugs

BUFFALO, N.Y. -- An antiretroviral drug for HIV, methadone for heroin addiction, a birth control pill and an antidepressant. For some AIDS patients, this is a daily medication regimen. Others take drugs to treat diabetes, opportunistic infections and side effects of antiretrovirals, while still others abuse alcohol, cocaine or heroin.

How do all of these substances affect how HIV drugs work and how do HIV drugs, in turn, affect the other drugs a patient takes?

That question is at the heart of research being conducted by the University at Buffalo's Laboratory for Antiviral Research, where researchers are developing innovative new methods of testing the blood and cells of HIV patients for these interactions.

The work is supported by a new, $2.3 million National Institutes of Health/National Institute for Drug Abuse grant to complete the first major study of complex drug interactions in AIDS patients.

"Fifteen years ago, we were treating people with one basic goal in mind: to prolong their lives," said Gene Morse, Pharm.D., principal investigator, professor and chair of the UB Department of Pharmacy Practice and associate dean of the School of Pharmacy and Pharmaceutical Sciences. "Now we have the drugs to suppress viral replication, but with them come another set of complications. Many of these drugs are interacting and it has been difficult to study all possible interactions during the FDA development process. We want to find out their net effect." The decision to propose a comprehensive study on how antiretroviral drugs interact with other drugs HIV patients take grew out of a recent, multi-year clinical pharmacology study of interactions with methadone by Morse and psychiatrists at New York City's Montefiore Hospital. "A big factor in treating HIV infection are those patients with concurrent substance addiction," explained Morse. "For example, some of the drugs patients take to treat HIV could actually put them into withdrawal from m

Contact: Ellen Goldbaum
716-645-5000 x1415
University at Buffalo

Page: 1 2 3

Related medicine news :

1. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
2. EuroVacc 02 HIV vaccine trial begins in February 2005
3. PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms
4. International trial of two microbicides begins
5. NIAID begins enrolling volunteers for novel HIV vaccine study
6. National Center for Children Exposed to Violence begins annual conference today
7. Enrollment begins for osteoarthritis initiative
8. Patients should be consulted before dialysis treatment begins
9. Clinical trial of new TB vaccine begins
10. First US tuberculosis vaccine trial in 60 years begins
11. UCSF begins study testing antiviral drug tenofovir to prevent HIV infection

Post Your Comments:

(Date:4/17/2019)... ... April 17, 2019 , ... Kadan Homecare, an award-winning ... announced today that it has received both the 2019 Best of Home Care® – ... are granted only to the top-ranking home care providers, based on client and caregiver ...
(Date:4/17/2019)... HAVEN, Conn. (PRWEB) , ... April 17, 2019 ... ... community for IBS sufferers, announced a new initiative this April to designate April ... and to show strong support for research & healthcare professionals in their pursuit ...
(Date:4/17/2019)... ... April 17, 2019 , ... Fertility Centers of Illinois ... an effort to unite millions of Americans aiming to remove the stigmas and ... initiative, Fertility Centers of Illinois is offering seven free physician-led webinars and free ...
(Date:4/17/2019)... ... April 17, 2019 , ... An upcoming episode of Innovations ... episode is scheduled to air 3Q 2019 on FOX Business. Check your local ... Biomedical Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to ...
(Date:4/17/2019)... ... 17, 2019 , ... Signaled.online is a notification service designed for personal use. ... the web resources and reminder. , The alarm can be useful while traveling abroad, ... you haven’t logged in to the website for several days (this period is set ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... April 17, 2019 , ... ... therapies for diseases involving mitochondrial dysfunction, announced yesterday at the 2019 Muscular ... TAZPOWER and open-label extension (OLE) clinical trial evaluating efficacy of elamipretide, an ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... ... Inc., (NYSE:VTR) and one of the nation’s largest owners and operators of medical ... of 11 healthcare industry experts during the Building Owners and Managers Association (BOMA) ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics’ ... alike. , Through years of experience helping sponsors manage complex oncology trials, ...
Breaking Medicine Technology:
Cached News: